121 related articles for article (PubMed ID: 21787336)
1. Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy.
Palmer CD; Guinan EC; Levy O
Biochem Soc Trans; 2011 Aug; 39(4):994-9. PubMed ID: 21787336
[TBL] [Abstract][Full Text] [Related]
2. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections.
Elsbach P; Weiss J
Infect Agents Dis; 1995 Jun; 4(2):102-9. PubMed ID: 7613727
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the bactericidal/permeability-increasing protein.
Levy O
Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
[TBL] [Abstract][Full Text] [Related]
4. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
Schultz H
Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
[TBL] [Abstract][Full Text] [Related]
5. The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways.
Holweg A; Schnare M; Gessner A
Biochem Soc Trans; 2011 Aug; 39(4):1045-50. PubMed ID: 21787345
[TBL] [Abstract][Full Text] [Related]
6. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
Elsbach P; Weiss J
Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
[TBL] [Abstract][Full Text] [Related]
7. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
8. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal/permeability increasing protein: a multifaceted protein with functions beyond LPS neutralization.
Balakrishnan A; Marathe SA; Joglekar M; Chakravortty D
Innate Immun; 2013; 19(4):339-47. PubMed ID: 23160386
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites.
Canny G; Levy O
Trends Immunol; 2008 Nov; 29(11):541-7. PubMed ID: 18838299
[TBL] [Abstract][Full Text] [Related]
11. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
[TBL] [Abstract][Full Text] [Related]
12. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
14. Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.
Levy O; Canny G; Serhan CN; Colgan SP
Biochem Soc Trans; 2003 Aug; 31(Pt 4):795-800. PubMed ID: 12887308
[TBL] [Abstract][Full Text] [Related]
15. The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.
Schultz H; Weiss JP
Clin Chim Acta; 2007 Sep; 384(1-2):12-23. PubMed ID: 17678885
[TBL] [Abstract][Full Text] [Related]
16. Characterization and expression analysis of bactericidal permeability-increasing protein (BPI) antimicrobial peptide gene from channel catfish Ictalurus punctatus.
Xu P; Bao B; He Q; Peatman E; He C; Liu Z
Dev Comp Immunol; 2005; 29(10):865-78. PubMed ID: 15896843
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial peptides/proteins--application to the therapy of sepsis].
Sawa T; Kurahashi K
Masui; 1999 Nov; 48(11):1186-93. PubMed ID: 10586550
[TBL] [Abstract][Full Text] [Related]
18. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
19. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
[TBL] [Abstract][Full Text] [Related]
20. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.
Canny G; Levy O; Furuta GT; Narravula-Alipati S; Sisson RB; Serhan CN; Colgan SP
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3902-7. PubMed ID: 11891303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
